Appendix B: Panel Roster and Financial Disclosures
Hepatitis B Virus
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Debika Bhattacharya | David Geffen School of Medicine at the University of California, Los Angeles | Gilead Sciences | Research Support (paid to institution) |
| Claudia Hawkins | Northwestern University Feinberg School of Medicine | None | N/A |
| Marion Peters | Northwestern University Feinberg School of Medicine | Aligos Therapeutics Antios Therapeutics |
Scientific Advisory Board |
| Philip Spradling | Centers for Disease Control and Prevention | None | N/A |
| Chloe Thio* | The Johns Hopkins University School of Medicine | AlloVir | Scientific Advisory Board |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Appendix B: Panel Roster and Financial Disclosures
Hepatitis B Virus
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Debika Bhattacharya | David Geffen School of Medicine at the University of California, Los Angeles | Gilead Sciences | Research Support (paid to institution) |
| Claudia Hawkins | Northwestern University Feinberg School of Medicine | None | N/A |
| Marion Peters | Northwestern University Feinberg School of Medicine | Aligos Therapeutics Antios Therapeutics |
Scientific Advisory Board |
| Philip Spradling | Centers for Disease Control and Prevention | None | N/A |
| Chloe Thio* | The Johns Hopkins University School of Medicine | AlloVir | Scientific Advisory Board |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Download Guidelines
- Section Only PDF (20.38 KB)|spaceless
- Full Guideline PDF (5.8 MB)|spaceless
- Tables Only PDF (1006.96 KB)|spaceless